Results for tag: "Mayzent"

Mayzent is a drug used to treat multiple sclerosis (MS). It is a sphingosine 1-phosphate receptor modulator, which works by blocking the action of certain proteins that cause inflammation in the central nervous system. Mayzent is used to reduce the frequency of relapses and slow the progression of disability in people with relapsing forms of MS. It is also used to treat active secondary progressive MS in adults. Mayzent is part of the larger Central Nervous System (CNS) drug market, which includes treatments for a variety of neurological conditions, such as Alzheimer's disease, Parkinson's disease, epilepsy, and stroke. CNS drugs are used to treat a wide range of symptoms, including pain, fatigue, and cognitive impairment. Some companies in the Mayzent market include Novartis, Biogen, Merck, and Sanofi. Show Less Read more